7178.KLSE YSP Southeast Asia Holding Bhd

Healthcare Pharmaceuticals Kuala Lumpur Exchange
Add to portfolio Ask AI about 7178.KLSE
1.92 MYR
Close of Oct 29, 2026
1.91 2.13
Market cap
MYR 272M
P/E
10.1x
P/B
0.64x
ROE
6.5%
Dividend yield
7.81%
Fundamental score
3.6/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 7178.KLSE undervalued?

Graham number
Price1.92
Graham value3.58
Discount46.3%

7178.KLSE trades 46.3% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

YSP Southeast Asia Holding Bhd fundamental analysis

17 of 22 checks passed

ROE 0/2

Low return on equity (6.5%), below 10%.

ROA 0/1

Return on assets (4.9%) is below the industry median (5.5%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-6.2%) is not above the 5-year average (4.0% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-6.2%) is below the industry median (15.6%).

Revenue Growth 1/2

Revenue grew 3.0% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (5.1%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 16.8x against interest expense, well covered.

PE vs Market 1/1

PE (10.1x) is below the market median (11.4x).

PE vs Industry 1/1

PE (10.1x) is below the industry median (16.6x).

PBV 1/1

Price to book (0.6x) is below the industry median (0.9x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 6.5, limit 22.5).

PEG 0/1

PEG on 5-year earnings growth is 2.51, above 1.

Dividend Yield 2/2

Dividend yield (7.8%) is in the top 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 8 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 85.0%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

About YSP Southeast Asia Holding Bhd

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemic…

Full company profile